The Brazilian Health Regulatory Agency (ANVISA) issued the regulation RDC No. 752/2022 .


On March 8, 2022 Brazil’s Anvisa and the U.S. Food and Drug Administration (FDA) have signed a Cooperation Statement aimed at maintaining and strengthening their collaboration mechanisms.  


Brazil’s National Health Surveillance Agency (Anvisa) and FDA  They signed a document that will continue the already consolidated cooperation in the area of health regulation, maintaining the exchange of technical information and exploring new partnership opportunities.

Partnerships that the Covid-19 Pandemic Brought to World Health!

Throughout the Covid-19 pandemic, the two agencies have been actively collaborating on product reviews and have established ongoing communication.

Anvisa and FDA participate in key international forums related to products subject to health surveillance.

Both agencies are national reference regulatory authorities within the Pan American Health Organization (PAHO), linked to the World Health Organization (WHO).


Since 2020 Anvisa has participated in the Orbis Project, coordinated by the FDA with the aim of speeding up the registration of and access to oncology drugs through joint analyses.

Orbis project established in May 2019 to provide a framework for simultaneous submission and review of oncology products among international partners.

Need Regulatory Affairs in Brazil or USA ? contact us!

About Global Regulatory Partners

Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices, pharmaceutical, cosmetic and Food Supplement companies globally.

GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, and Mexico. GRP helps many life science companies register their products in different countries in compliance with local regulations. 

Follow GRP on Social Media !

Subscribe to our Blogs & Newsletter

Share This Post: